Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

5 results
Display

A Case of Bilateral Pulmonary Sequestration

Kho BG, Koh MJ, Kim WJ, Kim HW, Huh CW, Chung HM, Kim HJ

  • KMID: 2319741
  • Tuberc Respir Dis.
  • 2012 Feb;72(2):187-190.
Pulmonary sequestration is a rare congenital anomaly of the lung in which it is separately supplied from the aorta or one of its branches. Bilateral pulmonary sequestration is very rare,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Adenocarcinoma Arising within Intra-Abdominal Bronchogenic Cyst

Park JS, Kim JW, Lim BJ, Park SK, Kho BG, Lim JY, Cho JY

  • KMID: 2264257
  • Korean J Med.
  • 2012 Mar;82(3):374-377.
Gastric foregut duplication cyst is a rare congenital anomaly. There have been very few reports of bronchogenic cysts in the abdominal cavity attached to the stomach. We report a case...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Cranial Nerve Palsy as a Paraneoplastic Syndrome in Non-Small Cell Lung Cancer

Lee YM, Sim WH, Yoon SO, Kim SY, Park JS, Kho BG, Byun MK, Choi YC, Kim HJ

Paraneoplastic neurologic syndrome is a group of assorted disorders resulting from damage to the nervous system in cancer, remote from primary site, and not related to metastasis, infection, or metabolic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Cytomegalovirus Colitis with Endoscopic Finding Resembling Crohn's Disease

Huh CW, Youn YH, Jung DH, Kim DW, Kho BG, Kim JH, Park H, Lee SI

Cytomegalovirus (CMV) colitis is common among immunocompromised patients, and often diagnosed by pathologic confirmation because it is associated with a diverse spectrum of clinical and endoscopic features. However, Crohn's disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression

Park HY, Oh IJ, Kho BG, Kim TO, Shin HJ, Park CK, Kwon YS, Kim YI, Lim SC, Kim YC, Choi YD

BACKGROUND: Programmed death-ligand 1 (PD-L1), a transmembrane protein, binds to the programmed death-1 (PD-1) receptor, and anti-PD-1 therapy enables immune responses against tumors. This study aimed to assess clinical characteristics...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr